Publication | Closed Access

Effects of clopidogrel pretreatment before percutaneous coronary intervention in patients treated with glycoprotein IIb/IIIa inhibitors (abciximab or tirofiban)

ThrombosisPercutaneous Coronary InterventionCardiovascular DiseaseGlycoprotein Iib/iiia InhibitorsMedicineCardiovascular PharmacologyPharmacotherapyPlatelet AntagonistPharmacologyAnticoagulantCardiologyClopidogrel PretreatmentCoronary Artery DiseaseAcute Myocardial Infarction